Skip to main content
Top
Published in: Diabetology International 1/2020

01-01-2020 | Obesity | Original Article

Higher circulating orosomucoid and lower early-phase insulin secretion in midlife Japanese with slower glucose disposal during oral glucose tolerance tests

Authors: Ayaka Tsuboi, Kaori Kitaoka, Megumu Yano, Mika Takeuchi, Satomi Minato, Miki Kurata, Gen Yoshino, Bin Wu, Tsutomu Kazumi, Keisuke Fukuo

Published in: Diabetology International | Issue 1/2020

Login to get access

Abstract

Objective

We examined whether serum orosomucoid, an acute phase protein as with C-reactive protein, in addition to insulin resistance and beta-cell dysfunction, was involved in glucose disposal during oral glucose tolerance tests.

Research design and methods

124 midlife Japanese (65 women, 66% with normal glucose tolerance) received dual-energy X-ray absorptiometry and 75 g oral glucose tolerance tests with multiple postload glucose and insulin measurements. Subjects were divided based on the relationship between postload and fasting glucose. Obesity measures, insulin resistance, insulin secretion, serum orosomucoid and adiponectin were cross-sectionally analyzed by analysis of variance and then Bonferroni’s multiple comparison procedure.

Results

In 10 subjects (group A) and 19 subjects (group B), postload glucose fell below fasting glucose at 1 h and 2 h, respectively. In the remaining 95 subjects (group C), postload glucose never fell below fasting glucose. The insulinogenic index was lower and area under the glucose curve was higher in groups B and C as compared to group A (both p<0.05), whereas the Matsuda index, the homeostasis model assessment of insulin resistance, adipose insulin resistance (the product of fasting free fatty acid and insulin) and area under the insulin curve did not differ. Although there was no difference in fat mass index, trunk/leg fat ratio and adiponectin, orosomucoid was higher in group C as compared to group A (p<0.05).

Conclusions

Lower early-phase insulin secretion and low-grade inflammation were associated with slower glucose disposal during an oral glucose tolerance test in midlife Japanese. The rate of glucose disposal was not related to adiposity and insulin resistance.
Literature
1.
go back to reference Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681–8.CrossRef Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681–8.CrossRef
2.
go back to reference Tillin T, Hughes AD, Godsland IF, et al. Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort. Diabetes Care. 2013;36:383–93.CrossRef Tillin T, Hughes AD, Godsland IF, et al. Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort. Diabetes Care. 2013;36:383–93.CrossRef
3.
go back to reference Lyssenko V, Almgren P, Anevski D, et al. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes. 2005;54:166–74.CrossRef Lyssenko V, Almgren P, Anevski D, et al. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes. 2005;54:166–74.CrossRef
4.
go back to reference DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88:787–835.CrossRef DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88:787–835.CrossRef
5.
go back to reference Matsumoto K, Miyake S, Yano M, et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care. 1997;20:1562–8.CrossRef Matsumoto K, Miyake S, Yano M, et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care. 1997;20:1562–8.CrossRef
6.
go back to reference Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract. 2004;66(Suppl. 1):S37–43.CrossRef Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract. 2004;66(Suppl. 1):S37–43.CrossRef
7.
go back to reference Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2011;96:2898–903.CrossRef Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2011;96:2898–903.CrossRef
8.
go back to reference Abdul-Ghani MA, Williams K, DeFronzo R, et al. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care. 2006;29:1613–8.CrossRef Abdul-Ghani MA, Williams K, DeFronzo R, et al. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care. 2006;29:1613–8.CrossRef
9.
go back to reference Luo Z, Lei H, Sun Y, et al. Orosomucoid, an acute response protein with multiple modulating activities. J Physiol Biochem. 2015;71:329–40.CrossRef Luo Z, Lei H, Sun Y, et al. Orosomucoid, an acute response protein with multiple modulating activities. J Physiol Biochem. 2015;71:329–40.CrossRef
10.
go back to reference Bao X, Borné Y, Johnson L, et al. Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis. Cardiovasc Diabetol. 2018;17(1):87.CrossRef Bao X, Borné Y, Johnson L, et al. Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis. Cardiovasc Diabetol. 2018;17(1):87.CrossRef
11.
go back to reference Tsuboi A, Minato S, Yano M, et al. Association of serum orosomucoid with 30-min plasma glucose and glucose excursion during oral glucose tolerance tests in non-obese young Japanese women. BMJ Open Diabetes Res Care. 2018;6(1):e000508.CrossRef Tsuboi A, Minato S, Yano M, et al. Association of serum orosomucoid with 30-min plasma glucose and glucose excursion during oral glucose tolerance tests in non-obese young Japanese women. BMJ Open Diabetes Res Care. 2018;6(1):e000508.CrossRef
12.
go back to reference Terazawa-Watanabe M, Tsuboi A, Fukuo K, et al. Association of adiponectin with serum preheparin lipoprotein lipase mass in women independent of fat mass and distribution, insulin resistance, and inflammation. Metab Syndr Relat Disord. 2014;12:416–21.CrossRef Terazawa-Watanabe M, Tsuboi A, Fukuo K, et al. Association of adiponectin with serum preheparin lipoprotein lipase mass in women independent of fat mass and distribution, insulin resistance, and inflammation. Metab Syndr Relat Disord. 2014;12:416–21.CrossRef
13.
go back to reference Tanaka M, Yoshida T, Bin W, et al. FTO, abdominal adiposity, fasting hyperglycemia associated with elevated HbA1c in Japanese middle-aged women. J Atheroscler Thromb. 2012;19:633–42.CrossRef Tanaka M, Yoshida T, Bin W, et al. FTO, abdominal adiposity, fasting hyperglycemia associated with elevated HbA1c in Japanese middle-aged women. J Atheroscler Thromb. 2012;19:633–42.CrossRef
14.
go back to reference Wu B, Huang J, Fukuo K, et al. Different associations of trunk and lower-body fat mass distribution with cardiometabolic risk factors between healthy, middle-aged men and women. Int J Endocrinol. 2018;4(2018):1289485. Wu B, Huang J, Fukuo K, et al. Different associations of trunk and lower-body fat mass distribution with cardiometabolic risk factors between healthy, middle-aged men and women. Int J Endocrinol. 2018;4(2018):1289485.
15.
go back to reference Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
16.
go back to reference Abdul-Ghani MA, Jenkinson CP, Richardson DK, et al. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006;55:1430–5.CrossRef Abdul-Ghani MA, Jenkinson CP, Richardson DK, et al. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006;55:1430–5.CrossRef
17.
go back to reference Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23:295–301.CrossRef Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23:295–301.CrossRef
18.
go back to reference Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–70.CrossRef Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–70.CrossRef
19.
go back to reference Malin SK, Kashyap SR, Hammel J, et al. Adjusting glucose-stimulated insulin secretion for adipose insulin resistance: An index of beta-cell function in obese adults. Diabetes Care. 2014;37:2940–6.CrossRef Malin SK, Kashyap SR, Hammel J, et al. Adjusting glucose-stimulated insulin secretion for adipose insulin resistance: An index of beta-cell function in obese adults. Diabetes Care. 2014;37:2940–6.CrossRef
20.
go back to reference American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–27.CrossRef American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–27.CrossRef
21.
go back to reference Lim U, Turner SD, Franke AA, et al. Predicting total, abdominal, visceral and hepatic adiposity with circulating biomarkers in Caucasian and Japanese American women. PLoS ONE. 2012;7(8):e43502.CrossRef Lim U, Turner SD, Franke AA, et al. Predicting total, abdominal, visceral and hepatic adiposity with circulating biomarkers in Caucasian and Japanese American women. PLoS ONE. 2012;7(8):e43502.CrossRef
22.
go back to reference Yabe D, Seino Y, Fukushima M, et al. β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians. Curr Diab Rep. 2015;15(6):602.CrossRef Yabe D, Seino Y, Fukushima M, et al. β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians. Curr Diab Rep. 2015;15(6):602.CrossRef
23.
go back to reference Fujimoto WY. Overview of non-insulin-dependent diabetes mellitus (NIDDM) in different population groups. Diabet Med. 1996;13(Suppl. 6):S7–10.CrossRef Fujimoto WY. Overview of non-insulin-dependent diabetes mellitus (NIDDM) in different population groups. Diabet Med. 1996;13(Suppl. 6):S7–10.CrossRef
24.
go back to reference Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98–107.CrossRef Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98–107.CrossRef
25.
go back to reference Connelly MA, Gruppen EG, Wolak-Dinsmore J, et al. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study. Clin Chim Acta. 2016;452:10–7.CrossRef Connelly MA, Gruppen EG, Wolak-Dinsmore J, et al. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study. Clin Chim Acta. 2016;452:10–7.CrossRef
26.
go back to reference Fizelova M, Jauhiainen R, Kangas AJ, et al. Differential associations of inflammatory markers with insulin sensitivity and secretion: the Prospective METSIM study. J Clin Endocrinol Metab. 2017;102:3600–9.CrossRef Fizelova M, Jauhiainen R, Kangas AJ, et al. Differential associations of inflammatory markers with insulin sensitivity and secretion: the Prospective METSIM study. J Clin Endocrinol Metab. 2017;102:3600–9.CrossRef
27.
go back to reference Würtz P, Tiainen M, Mäkinen VP, et al. Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care. 2012;35:1749–56.CrossRef Würtz P, Tiainen M, Mäkinen VP, et al. Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care. 2012;35:1749–56.CrossRef
28.
go back to reference Tsuboi A, Minato S, Yano M, et al. Higher circulating adiponectin and lower orosomucoid were associated with postload glucose ≤70 mg/dL, a possible inverse marker for dysglycemia, in young Japanese women. BMJ Open Diabetes Research and Care. 2019;7:e000596.CrossRef Tsuboi A, Minato S, Yano M, et al. Higher circulating adiponectin and lower orosomucoid were associated with postload glucose ≤70 mg/dL, a possible inverse marker for dysglycemia, in young Japanese women. BMJ Open Diabetes Research and Care. 2019;7:e000596.CrossRef
29.
go back to reference Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999;353:1649–52.CrossRef Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999;353:1649–52.CrossRef
30.
go back to reference Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes. 2003;52:1799–805.CrossRef Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes. 2003;52:1799–805.CrossRef
31.
go back to reference Muhammad IF, Borné Y, Hedblad B, et al. Acute-phase proteins and incidence of diabetes: a population-based cohort study. Acta Diabetol. 2016;53:981–9.CrossRef Muhammad IF, Borné Y, Hedblad B, et al. Acute-phase proteins and incidence of diabetes: a population-based cohort study. Acta Diabetol. 2016;53:981–9.CrossRef
32.
go back to reference Bonadonna RC, Saccomani MP, Seely L, et al. Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes. 1993;42:191–8.CrossRef Bonadonna RC, Saccomani MP, Seely L, et al. Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes. 1993;42:191–8.CrossRef
Metadata
Title
Higher circulating orosomucoid and lower early-phase insulin secretion in midlife Japanese with slower glucose disposal during oral glucose tolerance tests
Authors
Ayaka Tsuboi
Kaori Kitaoka
Megumu Yano
Mika Takeuchi
Satomi Minato
Miki Kurata
Gen Yoshino
Bin Wu
Tsutomu Kazumi
Keisuke Fukuo
Publication date
01-01-2020
Publisher
Springer Japan
Published in
Diabetology International / Issue 1/2020
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-019-00398-6

Other articles of this Issue 1/2020

Diabetology International 1/2020 Go to the issue